Bernard E. Weissman - Publications

University of North Carolina, Chapel Hill, Chapel Hill, NC 
Molecular Biology, Oncology, Neuroscience Biology

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Orlando KA, Douglas AK, Abudu A, Wang Y, Tessier-Cloutier B, Su W, Peters A, Sherman LS, Moore R, Nguyen V, Negri GL, Colborne S, Morin GB, Kommoss F, Lang JD, ... ... Weissman BE, et al. Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. Elife. 9. PMID 33355532 DOI: 10.7554/eLife.59073  0.48
2020 Song S, Nguyen V, Schrank T, Mulvaney K, Walter V, Wei D, Orvis T, Desai N, Zhang J, Hayes DN, Zheng Y, Major MB, Weissman BE. Loss of SWI/SNF chromatin remodeling alters NRF2 signaling in non-small cell lung carcinoma. Molecular Cancer Research : McR. PMID 32855269 DOI: 10.1158/1541-7786.Mcr-20-0082  0.44
2018 Kuwahara Y, Kennedy LM, Karnezis AN, Mora-Blanco EL, Rogers AB, Fletcher CD, Huntsman DG, Roberts CWM, Rathmell WK, Weissman BE. High Frequency of Ovarian Cyst Development in Vhl;Snf5 Mice. The American Journal of Pathology. PMID 29684361 DOI: 10.1016/J.Ajpath.2018.03.010  0.44
2015 Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, et al. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 6: 3165-77. PMID 25638158 DOI: 10.18632/Oncotarget.3078  1
2015 Kaur H, Hütt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, Weissman BE, Eberhart CG, Raabe EH. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. 74: 177-85. PMID 25575139 DOI: 10.1097/Nen.0000000000000161  1
2015 Wei D, Charboneau A, Chung H, Sakellariou-Thompson D, Davies B, Simpson DA, Kuwahara Y, Kaufmann WK, Roberts CWM, Weissman BE. Abstract 4787: Cyclin G2, a novel target of the SNF5/BAF47 tumor suppressor gene Cancer Research. 75: 4787-4787. DOI: 10.1158/1538-7445.Am2015-4787  0.44
2014 Biegel JA, Busse TM, Weissman BE. SWI/SNF chromatin remodeling complexes and cancer. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 166: 350-66. PMID 25169151 DOI: 10.1002/Ajmg.C.31410  1
2014 Orvis T, Hepperla A, Walter V, Song S, Simon J, Parker J, Wilkerson MD, Desai N, Major MB, Hayes DN, Davis IJ, Weissman B. BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. Cancer Research. 74: 6486-98. PMID 25115300 DOI: 10.1158/0008-5472.Can-14-0061  1
2014 Wei D, Goldfarb D, Song S, Cannon C, Yan F, Sakellariou-Thompson D, Emanuele M, Major MB, Weissman BE, Kuwahara Y. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development. Molecular Cancer Research : McR. 12: 1574-85. PMID 25009291 DOI: 10.1158/1541-7786.Mcr-14-0005  1
2014 Song S, Walter V, Karaca M, Li Y, Bartlett CS, Smiraglia DJ, Serber D, Sproul CD, Plass C, Zhang J, Hayes DN, Zheng Y, Weissman BE. Gene silencing associated with SWI/SNF complex loss during NSCLC development. Molecular Cancer Research : McR. 12: 560-70. PMID 24445599 DOI: 10.1158/1541-7786.Mcr-13-0427  1
2014 Wei D, Chung H, Simpson DA, Kaufmann WK, Weissman BE. Abstract 2245: Mechanism of replicative senescence induced by SNF5 loss Cancer Research. 74: 2245-2245. DOI: 10.1158/1538-7445.Am2014-2245  0.44
2013 Kuwahara Y, Wei D, Durand J, Weissman BE. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Molecular Cancer Research : McR. 11: 251-60. PMID 23364536 DOI: 10.1158/1541-7786.Mcr-12-0390  1
2013 Kuwahara Y, Mora-Blanco EL, Banine F, Rogers AB, Fletcher C, Sherman LS, Roberts CW, Weissman BE. Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development. International Journal of Cancer. Journal International Du Cancer. 132: 2767-77. PMID 23197309 DOI: 10.1002/Ijc.27976  1
2013 Wei D, Weissman BE, Kuwahara Y. Abstract 3821: Elucidating the role of PBRM1 in SNF5 regulated gene expression in malignant rhadboid tumors. Cancer Research. 73: 3821-3821. DOI: 10.1158/1538-7445.Am2013-3821  0.44
2012 Kuwahara Y, Mora-Blanco EL, Rogers A, Fletcher CD, Roberts CW, Weissman BE. Abstract 1359: Establishment and characterization of mouse malignant rhabdoid tumor cell lines Cancer Research. 72: 1359-1359. DOI: 10.1158/1538-7445.Am2012-1359  0.44
2011 DelBove J, Rosson G, Strobeck M, Chen J, Archer TK, Wang W, Knudsen ES, Weissman BE. Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics. 6: 1444-53. PMID 22139574 DOI: 10.4161/Epi.6.12.18492  1
2011 Bartlett C, Orvis TJ, Rosson GS, Weissman BE. BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest. Journal of Cellular Physiology. 226: 1989-97. PMID 21520050 DOI: 10.1002/Jcp.22533  1
2011 Davies B, Kuwahara Y, Charboneau A, Weissman B. Abstract 4028: Identification of novel binding targets of hSNF5 in malignant rhabdoid tumors Cancer Research. 71: 4028-4028. DOI: 10.1158/1538-7445.Am2011-4028  0.44
2011 Kuwahara Y, Durand J, Weissman BE. Abstract 212: Reexpression of hSNF5 regulates the transcriptional activity of the NOXA promoter through p53 independent mechanisms in malignant rhabdoid tumors Cellular and Molecular Biology. 71: 212-212. DOI: 10.1158/1538-7445.Am2011-212  0.44
2010 Cohen SM, Chastain PD, Rosson GB, Groh BS, Weissman BE, Kaufman DG, Bultman SJ. BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression. Nucleic Acids Research. 38: 6906-19. PMID 20571081 DOI: 10.1093/Nar/Gkq559  1
2010 Kuwahara Y, Charboneau A, Knudsen ES, Weissman BE. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Cancer Research. 70: 1854-65. PMID 20179200 DOI: 10.1158/0008-5472.Can-09-1922  1
2009 DelBove J, Kuwahara Y, Mora-Blanco EL, Godfrey V, Funkhouser WK, Fletcher CD, Van Dyke T, Roberts CW, Weissman BE. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice. Molecular Carcinogenesis. 48: 1139-48. PMID 19676100 DOI: 10.1002/Mc.20568  1
2008 Shen H, Powers N, Saini N, Comstock CE, Sharma A, Weaver K, Revelo MP, Gerald W, Williams E, Jessen WJ, Aronow BJ, Rosson G, Weissman B, Muchardt C, Yaniv M, et al. The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Research. 68: 10154-62. PMID 19074882 DOI: 10.1158/0008-5472.Can-08-1794  0.48
2007 Chai J, Lu X, Godfrey V, Fletcher C, Roberts CW, Van Dyke T, Weissman BE. Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation. Cancer Research. 67: 3002-9. PMID 17409406 DOI: 10.1158/0008-5472.Can-06-4207  1
2006 De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, et al. Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biology & Therapy. 5: 1588-99. PMID 17224636 DOI: 10.4161/Cbt.5.12.3660  1
2006 Charboneau A, Chai J, Jordan J, Funkhouser W, Judkins A, Biegel J, Weissman B. P-Akt expression distinguishes two types of malignant rhabdoid tumors. Journal of Cellular Physiology. 209: 422-7. PMID 16897758 DOI: 10.1002/Jcp.20737  1
2005 Chai J, Charboneau AL, Betz BL, Weissman BE. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Research. 65: 10192-8. PMID 16288006 DOI: 10.1158/0008-5472.Can-05-1896  1
2005 Rosson GB, Bartlett C, Reed W, Weissman BE. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. Journal of Cellular Physiology. 205: 286-94. PMID 15887247 DOI: 10.1002/Jcp.20397  1
2005 Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Research. 65: 3542-7. PMID 15867346 DOI: 10.1158/0008-5472.Can-04-3554  1
2005 Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF Molecular and Cellular Biology. 25: 2200-2215. PMID 15743818 DOI: 10.1128/Mcb.25.6.2200-2215.2005  1
2005 Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK. The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 13: 66-74. PMID 15722796 DOI: 10.1097/00129039-200503000-00011  1
2004 Rorie CJ, Weissman BE. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines. Cancer Research. 64: 7288-95. PMID 15492248 DOI: 10.1158/0008-5472.Can-04-1610  1
2004 Rorie CJ, Thomas VD, Chen P, Pierce HH, O'Bryan JP, Weissman BE. The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors. Cancer Research. 64: 1266-77. PMID 14973077 DOI: 10.1158/0008-5472.Can-03-3274  1
2003 Padalecki SS, Weldon KS, Reveles XT, Buller CL, Grubbs B, Cui Y, Yin JJ, Hall DC, Hummer BT, Weissman BE, Dallas M, Guise TA, Leach RJ, Johnson-Pais TL. Chromosome 18 suppresses prostate cancer metastases. Urologic Oncology. 21: 366-73. PMID 14670546 DOI: 10.1016/S1078-1439(03)00013-9  1
2003 Betz BL, Weissman BE. Hybrid capture of putative tumor suppressor genes. Methods in Molecular Biology (Clifton, N.J.). 222: 365-73. PMID 12710698 DOI: 10.1385/1-59259-328-3:365  1
2003 Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Research. 63: 560-6. PMID 12566296  1
2003 Hummer BT, Bartlett C, Henry E, Weissman BE. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity. Journal of Cellular Physiology. 194: 289-302. PMID 12548549 DOI: 10.1002/Jcp.10202  1
2002 Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 21: 5193-203. PMID 12149641 DOI: 10.1038/Sj.Onc.1205706  1
2002 Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene. 21: 1196-207. PMID 11850839 DOI: 10.1038/Sj/Onc/1205188  1
2002 Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE, Kowalik TF, Weissman BE, Knudsen ES. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. The Journal of Biological Chemistry. 277: 4782-9. PMID 11719516 DOI: 10.1074/Jbc.M109532200  1
2001 Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, Maitra A, Tomlinson G, Gazdar AF, Weissman BE, Bowcock AM, Baer R, Minna JD. Inactivation of human SRBC, located within the 11p15.5-P15.4 tumor suppressor region, in breast and lung cancers Cancer Research. 61: 7943-7949. PMID 11691816  1
2001 Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, Delattre O. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression Oncogene. 20: 3258-3265. PMID 11423975 DOI: 10.1038/Sj.Onc.1204437  1
2001 Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. Journal of Cellular Physiology. 186: 136-45. PMID 11147808 DOI: 10.1002/1097-4652(200101)186:1<136::Aid-Jcp1010>3.0.Co;2-4  1
2001 Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. The Journal of Biological Chemistry. 276: 9273-8. PMID 11108719 DOI: 10.1074/Jbc.M009747200  1
2000 Merrihew RV, Cruickshank RD, Conway K, Weissman BE. Altered response of a human squamous cell carcinoma cell line to 1,25-dihydroxyvitamin D3 after transfer of a normal chromosome 11 Experimental Cell Research. 259: 191-203. PMID 10942591 DOI: 10.1006/Excr.2000.4946  1
2000 Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES. BRG-1 is required for RB-mediated cell cycle arrest. Proceedings of the National Academy of Sciences of the United States of America. 97: 7748-53. PMID 10884406 DOI: 10.1073/Pnas.97.14.7748  1
2000 Miele ME, Jewett MD, Goldberg SF, Hyatt DL, Morelli C, Gualandi F, Rimessi P, Hicks DJ, Weissman BE, Barbanti-Brodano G, Welch DR. A human melanoma metastasis-suppressor locus maps to 6q16.3-q23 International Journal of Cancer. 86: 524-528. PMID 10797266 DOI: 10.1002/(Sici)1097-0215(20000515)86:4<524::Aid-Ijc13>3.0.Co;2-W  1
1999 DeCristofaro MF, Betz BL, Wang W, Weissman BE. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors. Oncogene. 18: 7559-65. PMID 10602515 DOI: 10.1038/Sj.Onc.1203168  1
1999 Mayo MW, Wang CY, Drouin SS, Madrid LV, Marshall AF, Reed JC, Weissman BE, Baldwin AS. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. The Embo Journal. 18: 3990-4003. PMID 10406804 DOI: 10.1093/Emboj/18.14.3990  1
1999 Isfort RJ, Cody DB, Lovell GJ, Gioeli D, Weissman BE, Doersen CJ. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids Molecular Carcinogenesis. 25: 30-41. PMID 10331742 DOI: 10.1002/(Sici)1098-2744(199905)25:1<30::Aid-Mc4>3.0.Co;2-N  1
1999 Coleman WB, Ricketts SL, Borchert KM, Presnell SC, Esch GL, McCullough KD, Weissman BE, Smith GJ, Grisham JW. Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines. International Journal of Oncology. 14: 957-63. PMID 10200348 DOI: 10.3892/Ijo.14.5.957  1
1999 Isaacs JS, Barrett JC, Weissman BE. Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6-mediated degradation. Molecular Carcinogenesis. 24: 70-7. PMID 10029413 DOI: 10.1002/(Sici)1098-2744(199901)24:1<70::Aid-Mc10>3.0.Co;2-5  1
1998 West A, Vojta PJ, Welch DR, Weissman BE. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1) Genomics. 54: 145-148. PMID 9806840 DOI: 10.1006/Geno.1998.5566  1
1998 Isaacs JS, Hardman R, Carman TA, Barrett JC, Weissman BE. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines Cell Growth and Differentiation. 9: 545-555. PMID 9690622  1
1998 Cooper PR, Smilinich NJ, Day CD, Nowak NJ, Reid LH, Pearsall RS, Reece M, Prawitt D, Landers J, Housman DE, Winterpacht A, Zabel BU, Pelletier J, Weissman BE, Shows TB, et al. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain. Genomics. 49: 38-51. PMID 9570947 DOI: 10.1006/Geno.1998.5221  1
1998 Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL, Weissman BE. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Molecular Carcinogenesis. 21: 111-20. PMID 9496911 DOI: 10.1002/(Sici)1098-2744(199802)21:2<111::Aid-Mc5>3.0.Co;2-Q  1
1997 Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Letters. 119: 149-55. PMID 9570365 DOI: 10.1016/S0304-3835(97)00273-5  1
1997 Crider-Miller SJ, Reid LH, Higgins MJ, Nowak NJ, Shows TB, Futreal PA, Weissman BE. Novel transcribed sequences within the BWS/WT2 region in 11p15.5: tissue-specific expression correlates with cancer type. Genomics. 46: 355-63. PMID 9441738 DOI: 10.1006/Geno.1997.5061  1
1997 Hall IJ, Gioeli D, Weissman BE, Tlsty TD. Identification of additional complementation groups that regulate genomic instability Genes Chromosomes and Cancer. 20: 103-112. PMID 9331561 DOI: 10.1002/(Sici)1098-2264(199710)20:2<103::Aid-Gcc1>3.0.Co;2-7  1
1997 Rodriguez P, Munroe D, Prawitt D, Chu LL, Bric E, Kim J, Reid LH, Davies C, Nakagama H, Loebbert R, Winterpacht A, Petruzzi MJ, Higgins MJ, Nowak N, Evans G, ... ... Weissman BE, et al. Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperone. Genomics. 44: 253-65. PMID 9325046 DOI: 10.1006/Geno.1997.4868  1
1997 Coleman WB, Esch GL, Borchert KM, McCullough KD, Reid LH, Weissman BE, Smith GJ, Grisham JW. Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines. Molecular Carcinogenesis. 19: 267-72. PMID 9290704 DOI: 10.1002/(Sici)1098-2744(199708)19:4<267::Aid-Mc8>3.0.Co;2-9  1
1997 Reid LH, Davies C, Cooper PR, Crider-Miller SJ, Sait SN, Nowak NJ, Evans G, Stanbridge EJ, deJong P, Shows TB, Weissman BE, Higgins MJ. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics. 43: 366-75. PMID 9268640 DOI: 10.1006/Geno.1997.4826  1
1997 Isaacs JS, Chiao C, Merrick BA, Selkirk JK, Barrett JC, Weissman BE. p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Research. 57: 2986-92. PMID 9230213  1
1997 Isaacs JS, Chen P, Garza A, Hansen MF, Barrett JC, Weissman BE. Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids. Oncogene. 14: 1669-78. PMID 9135068 DOI: 10.1038/Sj.Onc.1201001  1
1997 Gioeli D, Conway K, Weissman BE. Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures Cancer Research. 57: 1157-1165. PMID 9067287  1
1996 Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene Journal of the National Cancer Institute. 88: 1731-1737. PMID 8944003 DOI: 10.1093/Jnci/88.23.1731  1
1996 Reid LH, West A, Gioeli DG, Phillips KK, Kelleher KF, Araujo D, Stanbridge EJ, Dowdy SF, Gerhard DS, Weissman BE. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Human Molecular Genetics. 5: 239-47. PMID 8824880 DOI: 10.1093/Hmg/5.2.239  1
1996 Phillips KK, Welch DR, Miele ME, Lee JH, Wei LL, Weissman BE. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Research. 56: 1222-7. PMID 8640802  1
1996 Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massagué J, Weissman BE, Cordón-Cardó C. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors Cancer Research. 56: 1219-1221. PMID 8640801  1
1996 Reid LH, Crider-Miller SJ, West A, Lee MH, Massagué J, Weissman BE. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay Cancer Research. 56: 1214-1218. PMID 8640800  1
1996 Weissman BE, Gioeli D, Phillips K. Identification of tumor suppressor genes by microcell hybridization Methods: a Companion to Methods in Enzymology. 9: 38-46. DOI: 10.1006/Meth.1996.0006  1
1995 McMaster ML, Gessler M, Stanbridge EJ, Weissman BE. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line Cell Growth and Differentiation. 6: 1609-1617. PMID 9019166  1
1995 Chen P, Lin HH, Weissman BE. A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer Oncogene. 10: 577-586. PMID 7845683  1
1995 Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells Oncogene. 10: 1855-1864. PMID 7753561  1
1995 Coleman WB, McCullough KD, Esch GL, Civalier CJ, Livanos E, Weissman BE, Grisham JW, Smith GJ. Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11 Molecular Carcinogenesis. 13: 220-232. PMID 7646761 DOI: 10.1002/Mc.2940130405  1
1995 Weissman BE, Conway K. Genetic aspects of tumor suppressor genes Advances in Genome Biology. 3: 143-162. DOI: 10.1016/S1067-5701(06)80006-9  1
1994 Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ, Weissman BE. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene. 9: 255-62. PMID 8302587  1
1994 Chen P, Ellmore N, Weissman BE. Functional evidence for a second tumor suppressor gene on human chromosome 17 Molecular and Cellular Biology. 14: 534-542. PMID 8264622 DOI: 10.1128/Mcb.14.1.534  1
1992 Conway K, Morgan D, Phillips KK, Yuspa SH, Weissman BE. Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay. Cancer Research. 52: 6487-95. PMID 1358434  1
1992 Loh WE, Scrable HJ, Livanos E, Arboleda MJ, Cavenee WK, Oshimura M, Weissman BE. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma Proceedings of the National Academy of Sciences of the United States of America. 89: 1755-1759. PMID 1347425 DOI: 10.1073/Pnas.89.5.1755  1
1992 Parshad R, Price FM, Oshimura M, Barrett JC, Satoh H, Weissman BE, Stanbridge EJ, Sanford KK. Complementation of a DNA repair deficiency in six human tumor cell lines by chromosome 11. Human Genetics. 88: 524-8. PMID 1312990 DOI: 10.1007/Bf00219338  1
1991 Makino JK, Weissman BE. Identification of two 36-kD phosphoproteins associated with altered differentiation in retrovirus-transformed Balb/MK-2 mouse keratinocytes Pathobiology. 59: 384-390. PMID 1930691 DOI: 10.1159/000163682  1
1991 Dowdy SF, Lai Km, Weissman BE, Matsui Y, Hogan BLM, Stanbridge EJ. The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic wilms' microcell hybrid cells Nucleic Acids Research. 19: 5763-5769. PMID 1658743 DOI: 10.1093/Nar/19.20.5763  1
1991 Dowdy SF, Fasching CL, Araujo D, Lai KM, Livanos E, Weissman BE, Stanbridge EJ. Suppression of tumorigenicity in wilms tumor by the p15.5-p14 region of chromosome 11 Science. 254: 293-295. PMID 1656527 DOI: 10.1126/Science.1656527  1
1991 Dowdy SF, Weissman BE, Stanbridge EJ. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma Journal of Cellular Physiology. 147: 248-255. PMID 1645741 DOI: 10.1002/Jcp.1041470209  1
1990 Chen P, Weissman BE. A complementation analysis of suppression of tumorigenicity in human tumor cell hybrids Progress in Clinical and Biological Research. 340: 13-20. PMID 2196575  1
1990 Weissman BE. Genetic behaviour of tumorigenicity in human cancer Cancer Surveys. 9: 475-485. PMID 1983209  1
1989 Aaronson SA, Falco JP, Taylor WG, Cech AC, Marchese C, Finch PW, Rubin J, Weissman BE, Di Fiore PP. Pathways in which growth factors and oncogenes interact in epithelial cell mitogenic signal transduction. Annals of the New York Academy of Sciences. 567: 122-9. PMID 2802446 DOI: 10.1111/J.1749-6632.1989.Tb16464.X  1
1989 Weissman BE, Arboleda MJ, Kimoto KA, Macdonald MJ, Ochiai R, Der CJ. Activation of ras oncogenes in chemically transformed BALB/MK‐2 mouse keratinocytes Molecular Carcinogenesis. 2: 150-158. PMID 2506887 DOI: 10.1002/Mc.2940020308  1
1988 Pasquale SR, Jones GR, Doersen CJ, Weissman BE. Tumorigenicity and Oncogene Expression in Pediatric Cancers Cancer Research. 48: 2715-2719. PMID 3359432  1
1988 Falco JP, Taylor WG, Di Fiore PP, Weissman BE, Aaronson SA. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes Oncogene. 2: 573-578. PMID 3290805  1
1988 Coffey RJ, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β Molecular and Cellular Biology. 8: 3088-3093. PMID 2463471 DOI: 10.1128/Mcb.8.8.3088  1
1988 Coffey RJ, Sipes N, Bascom CC, Graves-Deal R, Pennington CY, Weissman BE, Moses HL. Growth Modulation of Mouse Keratinocytes by Transforming Growth Factors Cancer Research. 48: 1596-1602. PMID 2449957  1
1987 Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression Science. 236: 175-180. PMID 3031816 DOI: 10.1126/Science.3031816  1
1986 Vecchio G, Di Fiore PP, Fusco A, Colletta G, Weissman BE, Aaronson SA. In vitro transformation of epithelial cell by acute retroviruses Horizons in Biochemistry and Biophysics. 8: 415-470. PMID 3530955  1
1985 Weissman BE, Mark CS, Benedict WF, Stanbridge EJ. Expression of the N-ras oncogene in tumorigenic and non-tumorigenic HT 1080 fibrosarcoma X normal human fibroblast hybrid cells Progress in Clinical and Biological Research. 175: 141-149. PMID 3887427  1
1985 Weissman B, Aaronson SA. Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program Molecular and Cellular Biology. 5: 3386-3396. PMID 2427928 DOI: 10.1128/Mcb.5.12.3386  1
1984 Benedict WF, Mark C, Stanbridge EJ, Weissman BE. Tumorigenicity of Human HT1080 Fibrosarcoma x Normal Fibroblast Hybrids: Chromosome Dosage Dependency Cancer Research. 44: 3471-3479. PMID 6744274  1
1983 Weissman BE, Stanbridge EJ. Complementation of the tumorigenic phenotype in human cell hybrids Journal of the National Cancer Institute. 70: 667-672. PMID 6572754 DOI: 10.1093/Jnci/70.4.667  1
1983 Weissman BE, Stanbridge EJ. Complexity of control of tumorigenic expression in intraspecies hybrids of human SV40-transformed fibroblasts and normal human fibroblast cell lines Cytogenetics and Cell Genetics. 35: 263-268. PMID 6311488  1
1983 Weissman BE, Aaronson SA. BALB and kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines Cell. 32: 599-606. PMID 6297803 DOI: 10.1016/0092-8674(83)90479-8  1
1982 Stanbridge EJ, Der CJ, Doersen CJ, Nishimi RY, Peehl DM, Weissman BE, Wilkinson JE. Human cell hybrids: Analysis of transformation and tumorigenicity Science. 215: 252-259. PMID 7053574 DOI: 10.1126/Science.7053574  1
1980 Weissman B, Stanbridge EJ. Characterization of ouabain resistant, hypoxanthine phosphoribosyl transferase deficient human cells and their usefulness as a general method for the production of human cell hybrids Cytogenetics and Cell Genetics. 28: 227-239. PMID 6450667  1
Show low-probability matches.